Pipeline
The Science
About us
Investors

Hit enter to search or ESC to close

Webcast Presentation on New Data from the bioMUSE Natural History Study

May 30, 2024March 10, 2025 Alterity Therapeutics

Webcast Presentation

2024

Post navigation

Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study

Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar

Related Posts

Prana receives A$3.3 million R&D Tax Incentive

March 18, 2019August 16, 2022

Alterity AGM Investor Conference Call

November 20, 2019August 16, 2022

Notice of General Meeting 2019

March 13, 2019August 16, 2022

Recent Posts

Alterity Therapeutics Prominently Featured at the International MSA Congress
Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress
Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy
Appendix 4C – Q3 FY25 Quarterly Cash Flow Report
Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium

Recent Comments

Archives

Archives

Categories

ASX Announcements
Chairman's Address
Investor Announcement

Tags

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

LinkedIn
Facebook
X

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065